UK Life Sciences Company Directory

RNA therapeutics platform targeting multiple disease pathways

SymphoRNA is a company developing RNA medicines designed to address complex diseases by targeting multiple biological pathways simultaneously. Its platform uses a…

Human iPSC-based safety and genotoxicity testing for gene therapy vectors

TestAVec is a provider of in vitro safety testing services for gene therapy and viral vector products, serving academic researchers and industry developers. The company's human…

Probiotic microbiome platform for skin health and dermatological conditions

SkinBioTherapeutics is a biotechnology company developing microbiome-based technologies for skin health. Its proprietary platform harnesses lysates derived from probiotic bacteria…

Oligonucleotide therapeutics designed to upregulate protein expression

Orfonyx Bio is a biotechnology company developing genetic medicines that increase, rather than silence, the expression of therapeutic target proteins. Its platform generates…

UK national innovation centre for cell and gene therapy

Cell and Gene Therapy Catapult is a UK independent innovation organisation established to advance the cell and gene therapy industry by bridging the gap between research and…

Monoclonal antibodies for viral infectious disease

RQ Biotechnology is a passive immunisation company discovering and developing long-acting monoclonal antibodies to provide immediate protection against viral infections in…

Research antibodies, ELISA kits, proteins and peptides for life scientists

St John's Laboratory is a supplier of research antibodies, ELISA kits, proteins and peptides to academia and industry, with a strong focus on serving the UK academic community.…

Microbiome platform optimising hydroponic crop performance

Concert Bio is an agricultural biotechnology company developing microbial products to optimise crop performance in hydroponic greenhouses. Its platform combines the world's…

Cambridge R&D hub for GPCR-based drug discovery

Nxera Pharma UK is the Cambridge-based drug discovery arm of Tokyo-listed Nxera Pharma, formerly Sosei Heptares, operating from Granta Park with approximately 170 scientists. Its…

Synthetic mycolic acid antigens and point-of-care TB diagnostics

Diagnostig is a Welsh diagnostics and chemical synthesis company developing point-of-care immunoassay devices for the diagnosis of mycobacterial infections, including human and…

Antibody discovery biotech targeting GPCRs in inflammatory disease

DJS Antibodies is a biotechnology company developing monoclonal antibody therapeutics against G protein-coupled receptors and other previously intractable disease targets. Its…

Pre-clinical platelet function testing for drug discovery and safety

Platelet Services is a contract research organisation specialising in pre-clinical platelet function testing for pharmaceutical and biotechnology clients. The company provides…